Jaime Rodriguez Canales

2.3k total citations
20 papers, 610 citations indexed

About

Jaime Rodriguez Canales is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jaime Rodriguez Canales has authored 20 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Jaime Rodriguez Canales's work include Cancer Immunotherapy and Biomarkers (7 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Lung Cancer Research Studies (3 papers). Jaime Rodriguez Canales is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Lung Cancer Research Studies (3 papers). Jaime Rodriguez Canales collaborates with scholars based in United States, United Kingdom and Germany. Jaime Rodriguez Canales's co-authors include Ignacio I. Wistuba, Carmen Behrens, Pamela Villalobos, Boris Sepesi, Barbara Mino, Joe Y. Chang, Chad Tang, David H. Peng, Don L. Gibbons and Brian P. Hobbs and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Jaime Rodriguez Canales

20 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaime Rodriguez Canales United States	11	289	202	193	171	110	20	610
Masanori Someya Japan	18	348 1.2×	277 1.4×	229 1.2×	140 0.8×	149 1.4×	70	902
Jinbo Yue China	16	387 1.3×	152 0.8×	215 1.1×	148 0.9×	139 1.3×	61	748
Muyun Peng China	11	333 1.2×	217 1.1×	270 1.4×	78 0.5×	214 1.9×	34	710
Shichuan Zhang United States	6	162 0.6×	243 1.2×	346 1.8×	209 1.2×	79 0.7×	9	768
María T. Vlachaki United States	18	197 0.7×	196 1.0×	452 2.3×	268 1.6×	42 0.4×	51	958
Piera Balzarini Italy	18	321 1.1×	316 1.6×	503 2.6×	93 0.5×	175 1.6×	47	995
Stephanie Yoon United States	11	267 0.9×	334 1.7×	366 1.9×	132 0.8×	163 1.5×	34	781
Frédéric Kridelka Belgium	17	252 0.9×	220 1.1×	80 0.4×	110 0.6×	124 1.1×	53	721
W. Mai United States	9	155 0.5×	148 0.7×	397 2.1×	141 0.8×	69 0.6×	35	708
Damiënne Marcus Netherlands	10	252 0.9×	96 0.5×	157 0.8×	283 1.7×	76 0.7×	13	699

Countries citing papers authored by Jaime Rodriguez Canales

Since Specialization

Citations

This map shows the geographic impact of Jaime Rodriguez Canales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Rodriguez Canales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Rodriguez Canales more than expected).

Fields of papers citing papers by Jaime Rodriguez Canales

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Rodriguez Canales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Rodriguez Canales. The network helps show where Jaime Rodriguez Canales may publish in the future.

Co-authorship network of co-authors of Jaime Rodriguez Canales

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Rodriguez Canales. A scholar is included among the top collaborators of Jaime Rodriguez Canales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Rodriguez Canales. Jaime Rodriguez Canales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atkinson, James, et al.. (2023). Epitope Lability of Phosphorylated Biomarkers of the DNA Damage Response Pathway Results in Increased Vulnerability to Effects of Delayed or Incomplete Formalin Fixation. Journal of Histochemistry & Cytochemistry. 71(5). 237–257. 3 indexed citations

Xie, Mingchao, Andreas Spitzmüller, Harald Hessel, et al.. (2023). 1505 Spatial profiling of the SCLC tumor microenvironment defined by high MHC-I expression reveals association with functionally relevant antigen presentation. SHILAP Revista de lepidopterología. A1669–A1669. 1 indexed citations

Sousa, Luana Guimarães de, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.. (2022). ISA101 and nivolumab for HPV-16⁺ cancer: updated clinical efficacy and immune correlates of response. Journal for ImmunoTherapy of Cancer. 10(2). e004232–e004232. 58 indexed citations

Xie, Mingchao, Andreas Spitzmüller, Harald Hessel, et al.. (2022). 155 MHC class I antigen presentation is associated with an inflamed SCLC tumor microenvironment characterized by a higher density of cytotoxic T-cells in closer proximity to tumor cells. Regular and Young Investigator Award Abstracts. A168–A168. 1 indexed citations

Strittmatter, Nicole, Alan Race, Daniel Sutton, et al.. (2022). Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution. Theranostics. 12(5). 2162–2174. 15 indexed citations

Tong, Zhimin, Anuj Verma, Arlene M. Correa, et al.. (2019). Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Cancer Research. 79(13_Supplement). 3859–3859. 1 indexed citations

Peng, David H., Samrat T. Kundu, Jared J. Fradette, et al.. (2019). ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism. Science Translational Medicine. 11(483). 39 indexed citations

Tang, Chad, Brian P. Hobbs, Ahmed M. Amer, et al.. (2018). Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Scientific Reports. 8(1). 1922–1922. 113 indexed citations

Diamond, Jennifer R., Nathan Standifer, Maria Libera Ascierto, et al.. (2018). Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A). Annals of Oncology. 29. viii425–viii425. 2 indexed citations

10.

Glisson, Bonnie S., Erminia Massarelli, William N. William, et al.. (2017). Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer. Annals of Oncology. 28. v403–v404. 17 indexed citations

11.

Yu, Wen, Chad Tang, Brian P. Hobbs, et al.. (2017). Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(4). 1090–1097. 57 indexed citations

12.

Sepesi, Boris, Jaime Rodriguez Canales, Carmen Behrens, et al.. (2017). Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non–Small Cell Lung Cancer. Seminars in Thoracic and Cardiovascular Surgery. 29(3). 408–415. 21 indexed citations

13.

Sepesi, Boris, Jaime Rodriguez Canales, Carmen Behrens, et al.. (2017). Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(1). 223–223. 4 indexed citations

14.

Tong, Zhimin, Jianhu Zhang, Yawei Qiao, et al.. (2017). Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target. European Journal of Surgical Oncology. 43(11). 2222–2222. 1 indexed citations

15.

Weissferdt, Annikka, Neda Kalhor, Jaime Rodriguez Canales, et al.. (2016). Spindle cell and pleomorphic (“sarcomatoid”) carcinomas of the lung: an immunohistochemical analysis of 86 cases. Human Pathology. 59. 1–9. 24 indexed citations

16.

Peng, David H., Christin Ungewiss, Pan Tong, et al.. (2016). ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. Oncogene. 36(14). 1925–1938. 162 indexed citations

17.

Weissferdt, Annikka, Neda Kalhor, Jaime Rodriguez Canales, et al.. (2016). Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases. Applied immunohistochemistry & molecular morphology. 27(2). 125–133. 10 indexed citations

18.

Tang, Chad, Ahmed M. Amer, Brian P. Hobbs, et al.. (2016). Pathology-Based Non-Small Cell Lung Cancer Radiomics Signature Describing the Local Tumor Immune Environment: Discovery and Validation. International Journal of Radiation Oncology*Biology*Physics. 96(2). S42–S43. 4 indexed citations

19.

Massarelli, Erminia, Heather Lin, Lawrence E. Ginsberg, et al.. (2015). Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of Oncology. 26(7). 1476–1480. 69 indexed citations

20.

Leon, David A., et al.. (1997). Current status of injectable hormonal contraception, with special reference to the monthly method. Advances in Contraception. 13(4). 405–417. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact